156 related articles for article (PubMed ID: 32015503)
21. Chromosome alignment-maintaining phosphoprotein CHAMP1 plays a role in cell survival through regulating Mcl-1 expression.
Hino M; Iemura K; Ikeda M; Itoh G; Tanaka K
Cancer Sci; 2021 Sep; 112(9):3711-3721. PubMed ID: 34107118
[TBL] [Abstract][Full Text] [Related]
22. Mouse Noxa uses only the C-terminal BH3-domain to inactivate Mcl-1.
Weber A; Ausländer D; Häcker G
Apoptosis; 2013 Sep; 18(9):1093-105. PubMed ID: 23733106
[TBL] [Abstract][Full Text] [Related]
23. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
[TBL] [Abstract][Full Text] [Related]
24. Constitutive High Expression of NOXA Sensitizes Human Embryonic Stem Cells for Rapid Cell Death.
Basundra R; Kapoor S; Hollville E; Kiapour N; Beltran Lopez A; Marie Melchiorre N; Deshmukh M
Stem Cells; 2022 Mar; 40(1):49-58. PubMed ID: 35511861
[TBL] [Abstract][Full Text] [Related]
25. Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA.
Albershardt TC; Salerni BL; Soderquist RS; Bates DJ; Pletnev AA; Kisselev AF; Eastman A
J Biol Chem; 2011 Jul; 286(28):24882-95. PubMed ID: 21628457
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Wertz IE; Kusam S; Lam C; Okamoto T; Sandoval W; Anderson DJ; Helgason E; Ernst JA; Eby M; Liu J; Belmont LD; Kaminker JS; O'Rourke KM; Pujara K; Kohli PB; Johnson AR; Chiu ML; Lill JR; Jackson PK; Fairbrother WJ; Seshagiri S; Ludlam MJ; Leong KG; Dueber EC; Maecker H; Huang DC; Dixit VM
Nature; 2011 Mar; 471(7336):110-4. PubMed ID: 21368834
[TBL] [Abstract][Full Text] [Related]
27. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
[TBL] [Abstract][Full Text] [Related]
28. DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex.
Nakajima W; Sharma K; Lee JY; Maxim NT; Hicks MA; Vu TT; Luu A; Yeudall WA; Tanaka N; Harada H
Oncotarget; 2016 Jun; 7(24):36353-36365. PubMed ID: 27166195
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell sensitivity to stress-induced apoptosis through regulation of MiD49 protein.
Xu S; Cherok E; Das S; Li S; Roelofs BA; Ge SX; Polster BM; Boyman L; Lederer WJ; Wang C; Karbowski M
Mol Biol Cell; 2016 Jan; 27(2):349-59. PubMed ID: 26564796
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor.
Kawabata T; Tanimura S; Asai K; Kawasaki R; Matsumaru Y; Kohno M
J Biol Chem; 2012 Mar; 287(13):10289-10300. PubMed ID: 22270368
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Noxa-mediated apoptosis in Helicobacter pylori-infected gastric epithelial cells.
Rath S; Das L; Kokate SB; Pratheek BM; Chattopadhyay S; Goswami C; Chattopadhyay R; Crowe SE; Bhattacharyya A
FASEB J; 2015 Mar; 29(3):796-806. PubMed ID: 25404713
[TBL] [Abstract][Full Text] [Related]
32. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
[TBL] [Abstract][Full Text] [Related]
33. HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy.
Strappazzon F; Di Rita A; Peschiaroli A; Leoncini PP; Locatelli F; Melino G; Cecconi F
Cell Death Differ; 2020 Apr; 27(4):1155-1168. PubMed ID: 31434979
[TBL] [Abstract][Full Text] [Related]
34. Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways.
Zhang L; Lopez H; George NM; Liu X; Pang X; Luo X
Cell Death Differ; 2011 May; 18(5):864-73. PubMed ID: 21113147
[TBL] [Abstract][Full Text] [Related]
35. Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells.
Inoue C; Sobue S; Kawamoto Y; Nishizawa Y; Ichihara M; Abe A; Hayakawa F; Suzuki M; Nozawa Y; Murate T
Biochem Biophys Res Commun; 2020 May; 525(4):1074-1080. PubMed ID: 32184020
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis.
Arai S; Jonas O; Whitman MA; Corey E; Balk SP; Chen S
Clin Cancer Res; 2018 Nov; 24(21):5458-5470. PubMed ID: 30021909
[No Abstract] [Full Text] [Related]
37. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
38. BCL-XL regulates the timing of mitotic apoptosis independently of BCL2 and MCL1 compensation.
Yu CY; Yeung TK; Fu WK; Poon RYC
Cell Death Dis; 2024 Jan; 15(1):2. PubMed ID: 38172496
[TBL] [Abstract][Full Text] [Related]
39. The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents.
Karbon G; Haschka MD; Hackl H; Soratroi C; Rocamora-Reverte L; Parson W; Fiegl H; Villunger A
Cell Death Dis; 2021 Dec; 12(12):1151. PubMed ID: 34903710
[TBL] [Abstract][Full Text] [Related]
40. Understanding MCL1: from cellular function and regulation to pharmacological inhibition.
Sancho M; Leiva D; Lucendo E; Orzáez M
FEBS J; 2022 Oct; 289(20):6209-6234. PubMed ID: 34310025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
